There are 2867 resources available
946P - Non-examination of lymph nodes (LN) in early-stage non-small cell lung cancer (eNSCLC) is associated with wedge resections and underutilization of adjuvant (adv) chemotherapy
Presenter: Jay Lee
Session: Poster session 04
947P - Follow-up tests’ profitability in NSCLC: Experience of a tertiary hospital
Presenter: Virginia Calvo de Juan
Session: Poster session 04
949TiP - Neoadjuvant durvalumab in non-surgical early stage/locally advanced non-small cell lung cancer (NSCLC) followed by radical RT/CRT (IDEAR) study concept of a phase II investigator initiated clinical trial
Presenter: Catia Fava Gaspar
Session: Poster session 04
951P - Induction osimertinib followed by definitive sequential radiation therapy and/or surgery in unresectable EGFR-mutant stage III NSCLC: An open-label, single-arm, phase II study
Presenter: Nir Peled
Session: Poster session 04
952P - Effect of thoracic radiotherapy timing on prognosis for patients with late-staged lung adenocarcinoma harboring EGFR mutations
Presenter: Qi Wang
Session: Poster session 04
953P - EGFR mutation testing from pleural effusions of advanced lung adenocarcinoma patients in Serbia
Presenter: Milena Cavic
Session: Poster session 04
954P - Cemiplimab with platinum-based chemotherapy (chemo) for first-line (1L) locally advanced non-small cell lung cancer (laNSCLC): EMPOWER-Lung 3 subgroup analysis
Presenter: Ewa Kalinka
Session: Poster session 04
955P - Updated event-free survival of neoadjuvant toripalimab with chemotherapy for resectable stage III NSCLC (NeoTAP01 study)
Presenter: Ze-rui Zhao
Session: Poster session 04